These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 124199)

  • 21. Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain.
    Perry TL; Hansen S; Kloster M
    N Engl J Med; 1973 Feb; 288(7):337-42. PubMed ID: 4345566
    [No Abstract]   [Full Text] [Related]  

  • 22. Central cholinergic-anticholinergic antagonism in Huntington's chorea.
    Klawans HL; Rubovits R
    Neurology; 1972 Feb; 22(2):107-16. PubMed ID: 4257815
    [No Abstract]   [Full Text] [Related]  

  • 23. Pallidal GABA and chorea in Huntington's disease.
    Pearson SJ; Heathfield KW; Reynolds GP
    J Neural Transm Gen Sect; 1990; 81(3):241-6. PubMed ID: 2144428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopa as an antimetabolite in Huntington's disease.
    Baskin F; Rosenberg RN
    Lancet; 1973 Mar; 1(7803):582-3. PubMed ID: 4120646
    [No Abstract]   [Full Text] [Related]  

  • 25. Rational approaches to the pharmacotherapy of chorea.
    Chase TN
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():337-50. PubMed ID: 137504
    [No Abstract]   [Full Text] [Related]  

  • 26. Biochemical changes in Alzheimer's disease-senile dementia: neurotransmitters in senile dementia of the Alzheimer's type.
    Davies P
    Res Publ Assoc Res Nerv Ment Dis; 1979; 57():153-66. PubMed ID: 33427
    [No Abstract]   [Full Text] [Related]  

  • 27. Insight Into the Emerging Role of Striatal Neurotransmitters in the Pathophysiology of Parkinson's Disease and Huntington's Disease: A Review.
    Jamwal S; Kumar P
    Curr Neuropharmacol; 2019; 17(2):165-175. PubMed ID: 29512464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas. A PET study.
    Turjanski N; Weeks R; Dolan R; Harding AE; Brooks DJ
    Brain; 1995 Jun; 118 ( Pt 3)():689-96. PubMed ID: 7600086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of agonal status on measurements of GABA and glutamate decarboxylase in human post-mortem brain tissue from control and Huntington's chorea subjects.
    Spokes EG; Garrett NJ; Iversen LL
    J Neurochem; 1979 Sep; 33(3):773-8. PubMed ID: 158073
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacology of Huntington's chorea. Personal experience.
    Caraceni T; Giovannini P; Girotti F; Avanzini G
    Eur Neurol; 1977; 16(1-6):42-50. PubMed ID: 150332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia.
    Bird ED; Iversen LL
    Brain; 1974 Sep; 97(3):457-72. PubMed ID: 4157009
    [No Abstract]   [Full Text] [Related]  

  • 32. Huntington's disease: new approaches to an old problem. The Robert Wartenberg lecture.
    Martin JB
    Neurology; 1984 Aug; 34(8):1059-72. PubMed ID: 6146951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GABA and benzodiazepine receptors in basal ganglia function.
    Young AB; Pan HS; Ciliax BJ; Penney JB
    Neurosci Lett; 1984 Jun; 47(3):361-7. PubMed ID: 6089057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of GABA in post-mortem brain tissue from control, psychotic and Huntington's chorea subjects.
    Spokes EG; Garrett NJ; Rossor MN; Iversen LL
    J Neurol Sci; 1980 Dec; 48(3):303-13. PubMed ID: 6449563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Huntington's disease: current concepts of therapy.
    Goetz CG; Weiner WJ
    J Am Geriatr Soc; 1979 Jan; 27(1):23-6. PubMed ID: 153351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GABA content and glutamic acid decarboxylase activity in brain of Huntington's chorea patients and control subjects.
    Urquhart N; Perry TL; Hansen S; Kennedy J
    J Neurochem; 1975 May; 24(5):1071-5. PubMed ID: 124764
    [No Abstract]   [Full Text] [Related]  

  • 37. Cholinergic and dopaminergic mechanisms in Huntington's chorea.
    Aquilonius SM; Sjöström R
    Life Sci I; 1971 Apr; 10(7):405-14. PubMed ID: 4325138
    [No Abstract]   [Full Text] [Related]  

  • 38. [Recent neurobiological and related pharmaco-therapeutic acquisitions in Huntington's chorea].
    Carolei A; Del Castillo G
    Clin Ter; 1979 Sep; 90(6):591-621. PubMed ID: 43793
    [No Abstract]   [Full Text] [Related]  

  • 39. Chorea.
    Klawans HL
    Can J Neurol Sci; 1987 Aug; 14(3 Suppl):536-40. PubMed ID: 2445458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of agonists and antagonists of cholinergic N receptors on the GABA level and GAD activity of the rat hypothalamus].
    Sieklucka-Dziuba M; Kleinrok Z
    Ann Univ Mariae Curie Sklodowska Med; 1982; 37():301-7. PubMed ID: 6927081
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.